Osaka, Japan

Tomoyuki Furuta

USPTO Granted Patents = 5 

 


Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Suita, JP (2014)
  • Osaka, JP (2021 - 2022)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Tomoyuki Furuta: Innovator in Pharmaceutical Chemistry

Introduction

Tomoyuki Furuta is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on aminoquinazolinone derivatives. With a total of 5 patents to his name, Furuta continues to push the boundaries of medicinal chemistry.

Latest Patents

Furuta's latest patents include a 2-heteroaryl aminoquinazolinone derivative. This compound is represented by a specific formula and is described as a pharmaceutically acceptable salt. The compound features various substituents, including CR or N, and is designed to enhance therapeutic efficacy. The detailed structure of this derivative showcases the complexity and potential applications in drug development.

Career Highlights

Throughout his career, Tomoyuki Furuta has worked with prominent companies in the pharmaceutical industry. Notable among these are Sumitomo Pharma Co., Ltd. and Sumitomo Dainippon Pharma Oncology, Inc. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Furuta has collaborated with esteemed colleagues in his field, including Hiroyuki Kitano and Kazuto Mori. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of new pharmaceutical compounds.

Conclusion

Tomoyuki Furuta is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His innovative contributions and collaborations continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…